ERYtech Pharma has obtained authorization from Afssaps to open a pharmaceutical headquarters in Lyon.
The activity of this new headquarters will include the export of products made by hand in Europe.
The first manufacturing unit is designed in accordance with European Directives and the Food and Drug U.S. (FDA's) allows the production of clinical batches and allow the manufacture of commercial batches on an industrial scale.
"It is exceptional, especially for a company that takes 4 years operational and develops innovative pharmaceutical products in order to reach the best international standards of quality, reproducibility and safety. In my view, this is the first authority in our field. It is the recognition of the extensive skills and experience of the team, "said Yann Godfrin, cofounder and CEO of Pharma ERYtech.